Welcome to Novo Nordisk in the United States


Archive for 'September 2017'

    What it’s like to GOBOLDLY every day

    26 September 2017

    Matthias von Herrath, MD, Vice President of Novo Nordisk’s Diabetes R&D Center in Seattle, is one of the researchers featured in the GOBOLDLY campaign from the biopharmaceutical industry group, PhRMA. GOBOLDLY highlights the value America’s pharmaceutical companies bring to patients, society, and our economy.

    In this Q&A, Matthias shares some behind-the-scenes stories about his role with the campaign and what it’s really like to be on the front lines of finding a cure for diabetes.

     
    Read more

    An update on our efforts to help those in need…

    18 September 2017

    As we continue to see more and more unimaginable images from the largest US natural disaster ever, our hearts ache for everyone affected by the recent hurricanes in Texas, Louisiana, Florida, and the Caribbean. 

    While all of our employees in these areas are safe and accounted for, many experienced catastrophic flooding, home and property damage and related hardships. Many are still struggling with power and transportation issues and assessing the effect on their local communities, including our customers and partners, and the patients they serve. 

    Read more

    When you can’t take a day off from diabetes

    15 September 2017

    Scott Ross is an attorney and founding member of Novo Nordisk’s resource group for employees living with diabetes. Here Scott opens up about the everyday challenges of managing diabetes at work. He shares how his healthy lifestyle, strong resolve, and diabetes-friendly workplace have helped him rise above those challenges, and expresses his wish for all people with diabetes to have access to similar support and resources.

     
    Read more